Cart
Orders
Not available hereProduct Overview
Glutaone Inj. 1200mg is a South Korean prescription injectable medicine containing 1,200 mg of reduced glutathione per vial. The Korean product registration identifies Kuhnil Pharmaceutical Co., Ltd. as the registered manufacturer/importer. Glutaone is supplied as a white porous solid in a clear vial, with a documented package of 10 vials per box. Its Korean approved indication concerns the prevention of neurological disorders associated with cisplatin or similar chemotherapy. Although glutathione injections are sometimes marketed for cosmetic skin brightening, such claims should not be confused with the product's approved indication.
Key Features
- 1,200 mg Reduced Glutathione: Each vial contains 1,200 mg of glutathione in its reduced form (GSH), the active ingredient identified in the Korean pharmaceutical registration.
- Prescription Injectable Formulation: Glutaone is a prescription medicine supplied as a white porous solid for preparation as an injectable solution. It is not an oral supplement or a topical cosmetic product.
- Documented Excipient: Sodium bicarbonate is listed as an excipient in the Korean product information. The exact excipient quantity should be verified from the current product-specific label.
- 10-Vial Box: The Korean registration lists 10 vials per box, each containing 1,200 mg of reduced glutathione. Confirm the original packaging and supplied SKU.
- Registered Room-Temperature Storage: The Korean product information specifies storage in a tightly closed container at 1–30°C. Follow the current original carton and package insert.
Composition & Specifications
| Specification | Details |
|---|---|
| Product Name | Glutaone Inj. 1200mg |
| Korean Product Name | 글루타온주1200mg |
| Product Category | Prescription injectable medicine |
| Active Ingredient | Reduced Glutathione (GSH) |
| Active Ingredient Strength | 1,200 mg per vial |
| Listed Excipient | Sodium Bicarbonate |
| Dosage Form | White porous solid in a clear vial, intended for preparation as an injectable solution |
| Korean Registration Holder | Kuhnil Pharmaceutical Co., Ltd. (건일제약) |
| Country of Origin | Republic of Korea |
| Packaging | 10 vials per box |
| Korean Product Approval Date | November 21, 2014 |
| Korean Product Registration Code | 201405431 |
| ATC Classification | V03AB32 — Glutathione |
| Registered Storage Conditions | Tightly closed container; room temperature at 1–30°C |
| Korean Approved Indication | Prevention of neurological disorders associated with cisplatin or similar chemotherapy |
The specifications above refer to the Korean-registered Glutaone Inj. 1200mg product. Certain export listings associate Glutaone with Wells Pharm Tech, while the referenced Korean registration names Kuhnil Pharmaceutical. The registered product identity, manufacturer, batch details and destination-market authorization should therefore be verified against the exact supplied carton and current official documentation.
How Reduced Glutathione Works
Glutathione is an endogenous tripeptide composed of glutamate, cysteine and glycine. It occurs in reduced (GSH) and oxidized (GSSG) forms and participates in cellular redox regulation. Reduced glutathione helps maintain intracellular antioxidant defenses and serves as a substrate for enzymes involved in the metabolism of reactive oxygen species.
Glutathione also participates in conjugation reactions involved in the metabolism of certain endogenous and foreign compounds. These established biochemical roles explain its relevance to cellular antioxidant systems, but they do not establish that Glutaone injections produce cosmetic skin whitening, anti-aging effects or general wellness benefits.
The registered Korean indication for Glutaone Inj. concerns neurological complications associated with cisplatin or related chemotherapy. Clinical use must follow the product-specific approved labeling and the prescribing requirements of the destination market.
Product Presentation
The documented Glutaone Inj. 1200mg presentation contains 10 individual vials per box. Each vial is labeled with 1,200 mg of reduced glutathione.
| Item | Specification |
|---|---|
| Vial Strength | 1,200 mg Reduced Glutathione |
| Vials per Box | 10 |
| Total Labeled Active Ingredient | 12,000 mg per 10-vial box |
| Physical Form | White porous solid in a clear vial |
The figures above refer to labeled drug content, not to a recommended dose or administration schedule. Some distributor catalogs mention a 600 mg glutathione presentation, but a separate Korean registration for Glutaone Inj. 600mg was not established from the sources reviewed. Do not assume that a 600 mg listing represents the same registered product.
Professional Product Selection Considerations
Professional purchasers evaluating Glutaone Inj. should confirm the registered product identity, active ingredient strength, original package configuration and regulatory eligibility before considering procurement or clinical use.
- Verify the Exact Product: Confirm Glutaone Inj. 1200mg and the corresponding reduced glutathione content on the original vial and carton.
- Check the Registration Holder: The Korean drug record identifies Kuhnil Pharmaceutical. Exporter and distributor names should not automatically be treated as the legal manufacturer or registration holder.
- Confirm the 10-Vial Package: Verify the actual vial count, original packaging, batch number and expiration date against the commercial shipment.
- Review Authorized Indications: The Korean registration concerns chemotherapy-associated neurological disorders. Cosmetic skin-lightening claims are not established by this registered indication.
- Check Destination-Market Requirements: Importation, distribution, prescribing and administration of prescription injections depend on the applicable national regulatory framework.
Storage & Handling
The Korean product registration specifies storage in a tightly closed container at 1–30°C (34–86°F). Maintain the labeled storage conditions during warehousing and distribution. Check the original carton for the applicable expiration date and any additional market-specific requirements.
Glutaone Inj. is a prescription medicine intended for administration by appropriately qualified healthcare professionals. Product preparation and handling must follow the current official prescribing information. Do not use vials with damaged packaging or an expired shelf life.
The Korean prescribing information identifies rare serious hypersensitivity reactions, including anaphylactoid reactions, as well as rash and gastrointestinal adverse effects. Healthcare professionals should review the complete warnings, contraindications and precautions before use.
Frequently Asked Questions
What is the active ingredient in Glutaone Inj.?
Glutaone Inj. 1200mg contains 1,200 mg of reduced glutathione per vial. Sodium bicarbonate is listed as an excipient in the Korean product record.
How many vials are included in one box?
The Korean-registered Glutaone Inj. 1200mg presentation contains 10 vials per box, each labeled with 1,200 mg of reduced glutathione.
Who manufactures Glutaone Inj.?
The Korean pharmaceutical registration identifies Kuhnil Pharmaceutical Co., Ltd. as the manufacturer/importer entry. Some international supplier listings also associate the product with Wells Pharm Tech. The legal manufacturer and registration holder for the supplied SKU should be verified from its official packaging and documentation.
What is the approved indication for Glutaone Inj. in Korea?
The Korean prescribing information identifies the prevention of neurological disorders associated with cisplatin or similar chemotherapy as the approved indication.
Is Glutaone Inj. approved for skin whitening?
Skin whitening is not the indication listed in the referenced Korean registration. Marketing claims involving skin brightening, anti-aging or general detoxification should not be presented as approved clinical benefits without product-specific evidence and applicable regulatory authorization.
How should Glutaone Inj. be stored?
The Korean product information specifies storage in a tightly closed container at 1–30°C. Follow the current original label and preserve the required conditions during storage and distribution.